Evidence-Based Review: Supplements for Female Sexual Function - A Practical Guide for Integrative and Functional Medicine Perspective
- John Kim
- Dec 30, 2025
- 11 min read
Evidence-Based Review: Supplements for Female Sexual Function
A Practical Guide for Integrative and Functional Medicine Perspective
Edited by Yoon Hang Kim MD MPH
About Dr. Kim
Dr. Yoon Hang "John" Kim is a board-certified integrative medicine physician with over 20 years of clinical experience. He completed his integrative medicine fellowship at the University of Arizona under Dr. Andrew Weil and holds certifications in preventive medicine, medical acupuncture, and integrative/holistic medicine. Through his telemedicine practice, Dr. Kim specializes in autoimmune conditions, chronic pain, integrative oncology, and complex conditions including fibromyalgia, chronic fatigue, MCAS, and mold toxicity. He is the author of three books and more than 20 articles, and has helped establish integrative medicine programs at institutions nationwide.
Professional: www.yoonhangkim.com | Clinical: www.directintegrativecare.com
A Practical Guide for Integrative and Functional Medicine Perspective
Edited by Yoon Hang Kim MD MPH
Introduction: Why This Matters
Let's be honest—female sexual dysfunction is one of those topics that often gets pushed to the margins of clinical conversations. Yet it affects roughly 40% of women worldwide and can profoundly impact quality of life, intimate relationships, and overall well-being. In my two decades of clinical practice, I've found that many women feel dismissed when they bring up concerns about low libido, difficulty with arousal, or other sexual health issues.
This is where integrative medicine and functional medicine approaches shine. Rather than simply prescribing a pill and sending patients on their way, we have the opportunity to explore root causes—hormonal imbalances, chronic stress, nutritional deficiencies, relationship dynamics, and mental health factors like anxiety and depression. Sometimes the solution is a supplement. Often, it's a combination of targeted interventions, lifestyle changes, and addressing psychological contributors.
What follows is my synthesis of the current evidence on natural supplements for female sexual function. I've tried to be both thorough and practical—giving you the data you need to have informed conversations with your patients while being honest about the limitations of the research.
The Current State of Evidence
The landmark 2021 meta-analysis by Sha'ari and colleagues, published in Phytomedicine, remains our best starting point. Their systematic review of 20 studies identified Tribulus terrestris and Panax ginseng as showing the most robust evidence for improving female sexual function. Since then, we've seen additional research on ashwagandha, saffron, fenugreek, and maca—though the evidence quality remains predominantly low to moderate across the board.
Before diving into individual supplements, I want to emphasize something important: substantial placebo effects (up to 40% in some trials) complicate interpretation of these studies. Sexual function is deeply tied to psychological factors, expectations, and relationship dynamics. This doesn't mean supplements don't work—it means we need to be thoughtful about setting realistic expectations with patients.
Tribulus terrestris: The Strongest Evidence
If I had to pick one supplement with the most compelling data, it would be Tribulus terrestris. The Sha'ari meta-analysis found large effect sizes for overall sexual function (SMD = 1.12), sexual desire (SMD = 1.08), arousal (SMD = 1.03), and orgasm (SMD = 0.51)—all statistically significant compared to placebo.
What the Individual Trials Show
A double-blind RCT with 67 premenopausal women with hypoactive sexual desire disorder found that just 7.5 mg/day of Tribulus extract for 4 weeks produced significant improvements in total FSFI scores and the desire domain (p < 0.001). That's a remarkably low dose showing meaningful effects.
For postmenopausal women, an RCT using 750 mg/day for 120 days showed improvements in both FSFI and Sexual Quotient scores. Interestingly, serum testosterone levels didn't significantly change—suggesting the mechanism may not be straightforward testosterone modulation as many assume.
An open-label assessment of 120 women found that 88% showed improvement in total FSFI scores, with DHEA levels increasing significantly while testosterone remained stable. This hints at adrenal pathway involvement rather than direct gonadal effects.
How It Probably Works
Tribulus contains protodioscin, a steroidal saponin that may influence the hypothalamic-pituitary axis, potentially affecting LH and FSH secretion. The DHEA elevation suggests adrenal modulation. Animal studies hint at effects on follicular development, though human data is limited.
Practical Recommendations
Typical dosing ranges from 250–750 mg/day in divided doses for 4–16 weeks. Side effects are generally mild GI symptoms (gastric discomfort, occasional reflux). The 2020 systematic review by Martimbianco emphasized that evidence certainty remains "very low"—so shared decision-making with patients about realistic expectations is essential.
Ashwagandha: The Stress-Libido Connection
Ashwagandha (Withania somnifera) is one of my go-to recommendations, particularly for women where stress seems to be suppressing libido. We now have three well-designed RCTs specifically examining its effects on female sexual function.
The Clinical Evidence
2015 Pilot Study (n=50): Using 600 mg/day of high-concentration root extract (HCARE) for 8 weeks, researchers found significant improvements versus placebo in total FSFI (p < 0.001), arousal, lubrication, orgasm, and satisfaction. Notably, the desire domain did not reach significance—an important nuance for patient counseling.
2022 KSM-66 Study (n=80): This trial showed statistically significant improvement in all FSFI subscales including desire (p < 0.0001). Quality of life scores also improved. The KSM-66 extract may have advantages over other formulations.
2025 RCT (n=62): The most recent study confirmed improvements in FSFI (p = 0.002), Perceived Stress Scale (p = 0.0009), and SF-12 quality of life (p = 0.044). The correlation between stress reduction and sexual function improvement supports the adaptogenic mechanism.
Why It Works
Ashwagandha's adaptogenic properties reduce cortisol and normalize HPA axis function. Chronic stress is a major libido killer—elevated cortisol suppresses gonadal function and shifts the body into "survival mode" rather than "thriving mode." By addressing the stress response, ashwagandha may restore conditions favorable to healthy sexual function. Its anxiolytic and antidepressant effects likely contribute as well.
Dosing and Safety
Standard dosing is 300–600 mg/day of standardized root extract for 8+ weeks. Side effects are rare and mild (occasional nausea, drowsiness). Long-term safety studies in rats showed a no-observed-adverse-effect level of 2000 mg/kg/day, supporting a favorable safety profile at human therapeutic doses.
Saffron: Especially for SSRI-Induced Dysfunction
Saffron (Crocus sativus) deserves special attention for women experiencing antidepressant-induced sexual dysfunction—a frustratingly common clinical scenario. A meta-analysis found significant effects on arousal (p = 0.028) and lubrication (p = 0.03).
Key Studies
A 2022 three-center RCT enrolled 68 women with severe FSD. Those receiving 15 mg saffron twice daily showed 62% improvement from baseline at 6 weeks, with superiority over placebo in desire, lubrication, and satisfaction domains. The time × treatment interaction favored saffron (p = 0.050).
For fluoxetine-induced dysfunction specifically, earlier studies showed saffron improved arousal, lubrication, and pain—domains particularly affected by SSRIs.
A 2024 trial combining saffron (30 mg/day) with vitamin E (50 mg) showed overall sexual function improvement (AMD 4.6, p < 0.001), with benefits sustained 4 weeks post-intervention.
Mechanism
Saffron's bioactive compounds (crocin, safranal) enhance dopamine and glutamate neurotransmission—potentially counteracting SSRI effects on these pathways. Its antidepressant and anxiolytic properties address psychological aspects, while antinociceptive effects may reduce pain-related discomfort. Nitric oxide release promotes genital blood flow.
Practical Use
Typical dosing is 15–30 mg/day for 4–8 weeks. Within therapeutic ranges, saffron is well-tolerated. Cost can be a barrier given saffron's expense, but standardized supplements are more affordable than culinary-grade saffron.
Panax Ginseng: Meta-Analytic Support
Korean red ginseng has solid meta-analytic support for arousal (SMD = 0.54, p = 0.014) and desire (SMD = 0.59, p < 0.001) in the Sha'ari analysis.
Clinical Data
A crossover RCT with 32 menopausal women found Korean red ginseng 3 g/day significantly improved sexual arousal (p = 0.006), with benefits in desire, lubrication, orgasm, and satisfaction. A premenopausal study showed FSFI improvements after 8 weeks, though the difference versus placebo didn't reach significance—highlighting substantial placebo effects in this population.
How It Works
Ginsenosides enhance nitric oxide synthesis in vascular endothelium, producing vasodilatory effects that improve genital blood flow. Antioxidant protection of vascular endothelium and potential modulation of dopamine and acetylcholine neurotransmitters may also contribute.
Dosing
Standard dosing is 1–3 g/day of Korean red ginseng for 8+ weeks. Generally well-tolerated; occasional gastric discomfort reported.
Maca: Best for SSRI-Induced Dysfunction
Maca root (Lepidium meyenii) shows its strongest effects in women with SSRI-induced sexual dysfunction—a niche where we desperately need options.
The Evidence
A dose-finding pilot study found 3 g/day maca (versus 1.5 g/day) significantly improved ASEX and MGH-SFQ scores in women with SSRI-induced dysfunction, with libido specifically improving on the ASEX item (p = 0.028). The higher dose appears important.
A double-blind follow-up showed higher remission rates with maca versus placebo, with postmenopausal women showing particularly robust responses—though researchers noted this might relate to age rather than menopausal status specifically.
Mechanism Mystery
Interestingly, maca doesn't appear to have direct androgenic activity and doesn't significantly affect serum reproductive hormone levels. The mechanism remains unclear but may involve non-hormonal pathways affecting energy, mood, and central nervous system function. Sometimes the clinical effect matters more than understanding exactly why it works.
Practical Points
Use 1.5–3 g/day for 6–12 weeks. The higher dose (3 g/day) appears more effective. Maca is generally well-tolerated with minimal side effects. Available in various forms including gelatinized powder, which may be easier to digest.
Fenugreek: Hormonal Effects
Fenugreek (Trigonella foenum-graecum) is interesting because it actually moves hormones—something most botanicals don't reliably do.
Clinical Studies
Libifem® Study (n=80): 600 mg/day of standardized fenugreek seed extract in healthy menstruating women with self-reported low libido significantly increased estradiol and free testosterone levels versus placebo. Sexual desire and arousal improved.
FenuSMART Study (n=48): 250 mg twice daily for 42 days showed 41.6% of participants reporting relief from sexual problems and irritability, with significant increases in estradiol (p = 0.040), free testosterone (p = 0.025), and total testosterone (p = 0.012).
Mechanism
Fenugreek contains saponins with phytoestrogenic activity. Effects appear stronger in women with suboptimal baseline hormone levels—suggesting it may work by normalizing deficiencies rather than pushing levels supraphysiological. This makes it potentially useful for perimenopause and hormone balance optimization.
Dosing
Typical dosing is 500–600 mg/day of standardized extract for 6–8 weeks. Generally well-tolerated. May cause maple syrup-like body odor in some individuals (harmless but can be surprising for patients).
L-Arginine Combinations: Variable Results
A 2021 systematic review by Cieri-Hutcherson evaluated seven studies on L-arginine for HSDD. Six of seven reported improvements in FSFI scores—but the devil is in the details.
Key Findings
Combination products like ArginMax (L-arginine with Panax ginseng, Ginkgo biloba, damiana, vitamins and minerals) show more consistent benefits than L-arginine monotherapy. ArginMax studies showed 73.5% of women improved in satisfaction with overall sex life versus 37.2% with placebo (p < 0.01).
Results vary by menopausal status: premenopausal women showed improved desire and satisfaction; perimenopausal women showed improved intercourse frequency and vaginal dryness; postmenopausal women primarily showed increased desire (51% vs 8%, p = 0.008).
In cancer survivors, ArginMax didn't improve sexual function but did improve overall quality of life—a reminder that sexual function improvements don't always follow general well-being improvements.
Practical Notes
L-arginine enhances nitric oxide production for improved blood flow. Combination products likely work through multiple mechanisms. ArginMax has been shown to exhibit no estrogenic activity on bioassay, making it suitable for women avoiding hormone therapy. Standard dosing is 3 capsules twice daily for 4–12 weeks.
Intranasal Oxytocin: Not Ready for Primetime
Despite theoretical appeal, intranasal oxytocin hasn't lived up to expectations. A key randomized trial by Muin and colleagues (2015) found no significant superiority over placebo in improving FSFI scores in women with HSDD. The placebo group showed up to 40% improvement—highlighting just how powerful expectation and attention effects can be in sexual function research.
While endogenous oxytocin naturally rises during arousal and orgasm and contributes to bonding and satisfaction, exogenous administration doesn't reliably translate to improved desire or arousal. Some observational data suggest indirect enhancements through partner dynamics, but controlled evidence is lacking. Bottom line: I don't currently recommend intranasal oxytocin for low libido treatment.
The Elephant in the Room: Mind-Body Interventions
Here's something that might surprise you: psychological and lifestyle interventions often show effect sizes comparable or superior to supplements—and with arguably better evidence quality.
Mindfulness-Based Therapy
The research by Brotto and Basson (2014) found that group mindfulness therapy significantly improved sexual desire (the primary outcome), arousal, lubrication, satisfaction, and overall function. Increases in mindfulness skills and reductions in depressive symptoms predicted improvements in desire—suggesting mechanism.
A 2025 RCT of the eSense online intervention found both CBT and mindfulness-based therapy arms showed large effect sizes versus waitlist: desire/arousal (d > 0.90), sexual distress (d < −0.62), and overall function (d = 1.20–1.23). Effects maintained at 6-month follow-up. These are impressive numbers that rival or exceed most supplement trials.
Why This Matters for Integrative Practice
Sexual desire is profoundly psychological. Chronic stress, relationship dynamics, past trauma, body image concerns, and negative sexual beliefs all contribute to low libido. Supplements can play a supportive role, but addressing these psychological factors often produces the most durable results. Consider cognitive behavioral sex therapy, sensate focus exercises, communication training, and addressing avoidance behaviors as part of comprehensive treatment.
Putting It All Together: Evidence Summary
Strongest Evidence (Meta-analytic Support)
Tribulus terrestris: desire, arousal, orgasm, overall function
Panax ginseng: desire, arousal
Moderate Evidence (Multiple RCTs)
Ashwagandha: arousal, lubrication, orgasm, satisfaction (especially with stress component)
Saffron: arousal, lubrication, desire (especially for SSRI-induced dysfunction)
Fenugreek: desire, hormonal effects
Limited Evidence (Fewer/Smaller Trials)
Maca: best for SSRI-induced dysfunction, postmenopausal women
L-arginine combinations: variable by population
Insufficient Evidence
Ginkgo biloba: inconsistent results
Intranasal oxytocin: no superiority over placebo
Honest Assessment of Limitations
I want to be transparent about what we don't know. Most trials have small sample sizes (30–100 participants), heterogeneous populations, and variable dosing regimens that make direct comparisons difficult. Placebo effects are substantial—sometimes 40% of placebo groups show improvement. Many studies have moderate-to-high risk of bias, and industry funding is common. Most trials run only 4–12 weeks, leaving long-term efficacy and safety uncertain.
Does this mean supplements don't work? Not necessarily. It means we need to be humble about the strength of evidence and realistic with patients about what to expect.
Clinical Recommendations for Practice
Start with comprehensive assessment: Rule out medical conditions, medication effects, relationship factors, and psychological contributors. Consider functional medicine labs to identify underlying hormonal imbalances or nutritional deficiencies.
Practice shared decision-making: Discuss the limited evidence quality, uncertainties, and set realistic expectations. Some patients will respond dramatically; others may see modest or no benefit.
Consider combination approaches: Supplements work best as adjuncts to lifestyle modifications (stress reduction, exercise, sleep optimization) and psychological interventions (mindfulness, CBT, couples counseling).
Choose quality products: Recommend standardized extracts from reputable manufacturers with third-party testing. Product quality varies enormously in the supplement industry.
Allow adequate trial duration: Give supplements 8–12 weeks before assessing efficacy. Many patients expect faster results—manage these expectations upfront.
Monitor for interactions: Be aware of potential herb-drug interactions, particularly with hormonal therapies, antidepressants, and blood thinners.
At Direct Integrative Care, Dr. Kim is dedicated to guiding you on your path to wellness through a deeply personalized and supportive approach. We focus on integrative medicine, looking beyond symptoms to uncover the root causes of chronic conditions and develop a treatment plan tailored specifically to your unique health journey. By combining compassionate care with innovative therapies, our goal is to empower you with the knowledge and tools needed to achieve lasting health. We invite you to explore our website to learn more about how our patient-centered practice can help you find balance and vitality.
Yoon Hang Kim MD
Integrative & Functional Medicine Physician
Virtual Practice Serving IA, IL, MO, FL, GA, and TX
Key References
1. Sha'ari N, et al. Beneficial effects of natural products on female sexual dysfunction: A systematic review and meta-analysis. Phytomedicine. 2021;93:153760. PMID: 34638031
2. Martimbianco ALC, et al. Tribulus terrestris for female sexual dysfunction: A systematic review. Rev Bras Ginecol Obstet. 2020;42(7):427-435. PMID: 32736394
3. Dongre S, et al. Efficacy and safety of ashwagandha root extract in improving sexual function in women: A pilot study. Biomed Res Int. 2015;2015:284154. PMID: 26504795
4. Ajgaonkar A, et al. Efficacy and safety of ashwagandha root extract for improvement of sexual health in healthy women. Cureus. 2022;14(10):e30787. PMID: 36447681
5. Kashani L, et al. Crocus sativus (saffron) in the treatment of female sexual dysfunction: A three-center RCT. Avicenna J Phytomed. 2022;12(3):257-268. PMID: 36186931
6. Brotto LA, Basson R. Group mindfulness-based therapy significantly improves sexual desire in women. Behav Res Ther. 2014;57:43-54. PMID: 24814472
7. Cieri-Hutcherson NE, et al. Systematic review of L-arginine for hypoactive sexual desire disorder in women. Pharmacy (Basel). 2021;9(2):71.
8. Oh KJ, et al. Effects of Korean red ginseng on sexual arousal in menopausal women. J Sex Med. 2010;7(4):1469-1477.
9. Rao A, et al. Influence of fenugreek seed extract on testosterone, estradiol and sexual function in healthy menstruating women. Phytother Res. 2015;29(8):1123-1130.
10. Dording CM, et al. A double-blind placebo-controlled trial of maca root for antidepressant-induced sexual dysfunction. Evid Based Complement Alternat Med. 2015;2015:949036.
11. Muin DA, et al. Effect of long-term intranasal oxytocin on sexual dysfunction: A randomized trial. Fertil Steril. 2015;104(3):612-619.
12. Ranjbar H, Ashrafizaveh A. Effects of saffron on sexual dysfunction among men and women: A systematic review and meta-analysis. Avicenna J Phytomed. 2019;9(5):419-427.
Disclaimer: This review is for educational purposes only. Individual responses to supplements vary significantly. Consultation with a qualified healthcare professional is essential before initiating any supplement or therapy for sexual dysfunction. Supplements may interact with medications or underlying conditions.
Comments